Articles

THE SKYE FELL AFTER MUTED INTERIM DATA

10 October 2025

THE SKYE FELL AFTER MUTED INTERIM DATA

Skye Bioscience (NASDAQ: SKYE) released its Phase 2a results for its experimental obesity drug, nimacimab, and...

Read more
IS IT TIME TO LOOK AT THIS CANADIAN HOUSING STOCK

09 October 2025

IS IT TIME TO LOOK AT THIS CANADIAN HOUSING STOCK

QUICK FACTS Trading Symbols: AEP Share Price Today: $0.80 Shares Outstanding: 70.3 million Market Capitalization: $56...

Read more
OVID – PHASE 1 TRIAL GOOD ENOUGH, CAPITAL RAISE DOES RAISE SOME QUESTIONS

08 October 2025

OVID – PHASE 1 TRIAL GOOD ENOUGH, CAPITAL RAISE DOES RAISE SOME QUESTIONS

Ovid Therapeutics (OVID – NASDAQ) came out with their Phase 1 study results in OV329 targeting...

Read more
THE REAL SPARE CAPACITY

03 October 2025

THE REAL SPARE CAPACITY

The talk of the town in the oil market is spare capacity. OPEC+ spare capacity. When...

Read more
Canary Gold–BRAZ-CSE / CNYGF-OTC

02 October 2025

Canary Gold–BRAZ-CSE / CNYGF-OTC

The Massive, Simple, Scalable Gold Play You’ve Never Heard Of—Yet Unique ideas are rare in mining/mineral...

Read more

Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.